Opportunity Information: Apply for SP 18 006
The Strategic Prevention Framework Partnerships for Success grant opportunity (Funding Opportunity Number SP 18 006) is a discretionary grant offered by the U.S. Department of Health and Human Services through the Substance Abuse and Mental Health Services Administration (SAMHSA), specifically its Center for Substance Abuse Prevention (CSAP). For FY 2018, the program focus is framed as "Improving Access to Overdose Treatment" (short title: OD Treatment Access). The overall purpose is to reduce opioid overdose deaths and related harms by expanding community access to FDA-approved overdose reversal drugs or devices for emergency treatment of known or suspected opioid overdose, while also strengthening the connections that move overdose survivors into ongoing substance use disorder treatment.
The core idea behind the program is practical and community-facing: SAMHSA intends to fund organizations and clinicians who are positioned to increase prescribing, co-prescribing, and broader availability of overdose reversal medications, then spread those practices outward by training other prescribers and key community supporters. Award recipients are expected to work collaboratively with other prescribers at the local level to develop and refine best practices for prescribing and co-prescribing overdose reversal drugs. Once these best practices are established, recipients must actively train prescribers across important community sectors and also train individuals who support people at high risk of overdose, helping to ensure the tools and knowledge to respond to an overdose are not confined to a single clinic or program.
A major backbone resource for this effort is SAMHSA's Opioid Overdose Prevention Toolkit, originally released in 2013 to help communities prevent overdose deaths and adverse events. The grant program explicitly calls for using this toolkit along with other resources to train and equip health care providers and pharmacists on appropriate prescribing practices for overdose treatment drugs or devices that are approved or cleared under the Federal Food, Drug, and Cosmetic Act. In other words, the program is not just about purchasing or distributing medication; it is also about building consistent, evidence-informed prescribing practices and making sure the professionals who can expand access (including pharmacists, where relevant) have the training and support to do it safely and effectively.
Another central requirement is making sure overdose response does not end at reversal. The program stresses that recipients must establish protocols that connect patients who have experienced a drug overdose to appropriate ongoing treatment. This includes medication-assisted treatment (often referred to as MAT) and access to counseling and behavioral therapies that support recovery and reduce the risk of repeat overdose. The expectation is that grantees will help create a clear pathway from the emergency event to longer-term care, improving continuity and reducing the common gap where individuals are revived but never successfully linked to treatment.
Eligibility is targeted to entities that can directly influence prescribing and treatment access. SAMHSA indicates it will award OD Treatment Access funds to Federally Qualified Health Centers (FQHCs), Opioid Treatment Programs, and practitioners who hold a waiver to prescribe buprenorphine. These applicant types are singled out because they are already embedded in the health care and treatment infrastructure and can more quickly operationalize training, protocols, and expanded access.
From an administrative standpoint, this is a grant (Funding Instrument Type: Grant) in the health category (Funding Activity Category: Health), associated with CFDA number 93.243. The opportunity was posted on April 5, 2018, with an original application closing date of June 4, 2018. SAMHSA anticipated making about five awards, with an award ceiling of $200,000 per award. The limited number of expected awards and the clear ceiling suggest a focused cohort model, where a small number of recipients implement and demonstrate strong local partnership approaches that can be replicated elsewhere.
In summary, this opportunity funds a combination of expanded overdose reversal access, local prescriber partnership building, and training-based dissemination of best practices, all paired with concrete protocols that connect overdose survivors to medication-assisted treatment and counseling. The program is designed to move communities beyond isolated overdose response and toward a coordinated system where reversal medication access is widespread and every overdose event becomes an actionable point of entry into effective treatment.Apply for SP 18 006
- The Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis in the health sector is offering a public funding opportunity titled "Strategic Prevention Framework Partnerships for Success" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.243.
- This funding opportunity was created on Apr 05, 2018.
- Applicants must submit their applications by Jun 04, 2018. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $200,000.00 in funding.
- The number of recipients for this funding is limited to 5 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the Strategic Prevention Framework Partnerships for Success (SPF-PFS) OD Treatment Access grant?
The Strategic Prevention Framework Partnerships for Success grant opportunity (Funding Opportunity Number SP 18 006) is a discretionary grant from the U.S. Department of Health and Human Services, administered by the Substance Abuse and Mental Health Services Administration (SAMHSA) through its Center for Substance Abuse Prevention (CSAP). For FY 2018, the program focus is titled "Improving Access to Overdose Treatment" (short title: OD Treatment Access).
What is the main purpose of this funding opportunity?
The overall purpose is to reduce opioid overdose deaths and related harms by expanding community access to FDA-approved overdose reversal drugs or devices for emergency treatment of known or suspected opioid overdose, while strengthening connections that move overdose survivors into ongoing substance use disorder treatment.
What outcomes is SAMHSA trying to achieve through this program?
The program is designed to (1) increase the prescribing, co-prescribing, and availability of overdose reversal medications, (2) spread best practices by training other prescribers and key community supporters, and (3) ensure overdose survivors are connected to ongoing treatment such as medication-assisted treatment (MAT) and counseling/behavioral therapies.
Is this grant only about distributing or purchasing overdose reversal medications?
No. The opportunity emphasizes both expanding access to overdose reversal medications and building consistent, evidence-informed prescribing practices. Training and implementation of best practices are core expectations, not just medication distribution.
What kinds of medications or devices are supported under this program?
The program focuses on overdose treatment drugs or devices that are FDA-approved or cleared under the Federal Food, Drug, and Cosmetic Act for emergency treatment of known or suspected opioid overdose.
What role do prescribers play in this grant?
Recipients are expected to increase prescribing and co-prescribing of overdose reversal medications, collaborate with other local prescribers to develop and refine best practices, and then train prescribers across key community sectors to expand adoption of those practices.
What is meant by "co-prescribing" in the context of this grant?
Within the program description, co-prescribing refers to practices that expand access by ensuring overdose reversal medication is prescribed alongside other relevant medications or in situations where individuals are at higher risk of opioid overdose, as part of improved prescribing practices.
Who else must be trained besides prescribers?
In addition to training prescribers, recipients must train individuals who support people at high risk of overdose. The intent is to ensure overdose response tools and knowledge extend beyond a single clinic or program and reach key community supporters.
Does the opportunity mention any required training resources or guidance?
Yes. A central backbone resource is SAMHSA's Opioid Overdose Prevention Toolkit (originally released in 2013). The program explicitly calls for using this toolkit, along with other resources, to train and equip health care providers and pharmacists on appropriate prescribing practices for overdose treatment drugs or devices.
Are pharmacists included in the scope of this program?
Yes. The grant calls for training and equipping health care providers and pharmacists (where relevant) to support safe and effective prescribing practices and broader community access.
What is the expectation for connecting overdose survivors to treatment?
The program stresses that overdose response should not end at reversal. Recipients must establish protocols that connect patients who have experienced an overdose to appropriate ongoing treatment, including medication-assisted treatment (MAT) and access to counseling and behavioral therapies.
What types of organizations are eligible to apply?
SAMHSA indicates it will award OD Treatment Access funds to Federally Qualified Health Centers (FQHCs), Opioid Treatment Programs, and practitioners who hold a waiver to prescribe buprenorphine.
Why are these specific applicant types targeted for eligibility?
They are singled out because they are embedded in the health care and treatment infrastructure and can more quickly operationalize expanded access, training, protocols, and linkages to treatment.
Which federal agencies are associated with this funding opportunity?
The funding comes from the U.S. Department of Health and Human Services (HHS) through SAMHSA, specifically SAMHSA's Center for Substance Abuse Prevention (CSAP).
What kind of funding instrument is this?
This opportunity uses a grant as the funding instrument type (Funding Instrument Type: Grant).
What is the funding activity category?
The Funding Activity Category is Health.
What CFDA number is associated with this opportunity?
The opportunity is associated with CFDA number 93.243.
When was the opportunity posted and when did it close?
The opportunity was posted on April 5, 2018. The original application closing date was June 4, 2018.
How many awards did SAMHSA expect to make?
SAMHSA anticipated making about five awards.
What was the maximum award amount?
The award ceiling was $200,000 per award.
What does the limited number of awards suggest about the program approach?
With about five expected awards and a defined ceiling, the opportunity suggests a focused cohort model where a small number of recipients implement and demonstrate strong local partnership approaches that may be replicable in other communities.
What are recipients expected to do at the local community level?
Recipients are expected to work collaboratively with other prescribers to develop and refine best practices, then disseminate those practices by training prescribers across key community sectors and training community supporters of individuals at high risk of overdose.
How does this program address the gap between emergency overdose reversal and long-term recovery?
By requiring protocols that connect overdose survivors to ongoing treatment (including MAT and counseling/behavioral therapies), the program aims to turn an overdose event into a clear point of entry into effective treatment and reduce the likelihood of repeat overdose.
What is the short title of the FY 2018 program focus?
The short title provided is OD Treatment Access.
Where does the program place emphasis: individual clinics or broader community systems?
The program is designed to move beyond isolated overdose response by spreading best practices outward through training and partnerships so that access and knowledge are not confined to a single clinic or program.
What does the opportunity say about best practices?
A key expectation is that recipients develop and refine best practices for prescribing and co-prescribing overdose reversal drugs in collaboration with other local prescribers, and then train others to adopt those practices across the community.
Does the opportunity mention medication-assisted treatment (MAT) explicitly?
Yes. The opportunity identifies medication-assisted treatment (MAT), along with counseling and behavioral therapies, as part of the ongoing treatment linkages that grantees must support for overdose survivors.
Browse more opportunities from the same category: Health
Next opportunity: Veterans Accelerated Learning for Licensed Occupations Project
Previous opportunity: Recovery Efforts for the White Wartyback
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for SP 18 006
Applicants also applied for:
Applicants who have applied for this opportunity (SP 18 006) also looked into and applied for these:
| Funding Opportunity |
|---|
| Improving the Health of Americans Through Prevention and Management of Diabetes and Heart Disease and Stroke-Financed in part by 2018 Prevention and Public Health Funds (PPHF) Apply for CDC RFA DP18 1815PPHF18 Funding Number: CDC RFA DP18 1815PPHF18 Agency: Department of Health and Human Services, Centers for Disease Control - NCCDPHP Category: Health Funding Amount: $3,000,000 |
| Mental Health Awareness Training Grants Apply for SM 18 009 Funding Number: SM 18 009 Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis Category: Health Funding Amount: $125,000 |
| Community Programs for Outreach and Intervention with Youth and Young Adults at Clinical High Risk for Psychosis (Short Title: CHR-P) Apply for SM 18 012 Funding Number: SM 18 012 Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis Category: Health Funding Amount: $400,000 |
| Promoting, Strengthening and Enhancing Disease Prevention by Collaboration with Targeted Stakeholders Apply for CDC RFA IP18 1804 Funding Number: CDC RFA IP18 1804 Agency: Department of Health and Human Services, Centers for Disease Control - NCIRD Category: Health Funding Amount: $275,000 |
| Improving Implementation of Immunization Practice Standards by National Pharmacy Organizations--Financed Solely by PPHF 2018 Prevention and Public Health Funds Apply for CDC RFA IP18 1803PPHF18 Funding Number: CDC RFA IP18 1803PPHF18 Agency: Department of Health and Human Services, Centers for Disease Control - NCIRD Category: Health Funding Amount: $200,000 |
| Geriatrics and Clinical Gerontology Research to Address Health Disparities in the U.S. (Admin Supp Clinical Trial Not Allowed) Apply for PA 18 751 Funding Number: PA 18 751 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $45,500 |
| Assisting the Ministry of Health and Social Services (MOHSS) in Providing Critical Human Resources for Health to Achieve HIV Epidemic Control in Namibia under PEPFAR Apply for CDC RFA GH16 16400201SUPP18 Funding Number: CDC RFA GH16 16400201SUPP18 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: $1,551,929 |
| State Physical Activity and Nutrition Program Apply for CDC RFA DP18 1807 Funding Number: CDC RFA DP18 1807 Agency: Department of Health and Human Services, Centers for Disease Control - NCCDPHP Category: Health Funding Amount: $1,300,000 |
| UA6 Life Course Intervention Research Network (LCI-RN) Apply for HRSA 18 103 Funding Number: HRSA 18 103 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $1,200,000 |
| Networking2Save: CDCs National Network Approach to Preventing and Controlling Tobacco-related Cancers in Special Populations Apply for CDC RFA DP18 1808 Funding Number: CDC RFA DP18 1808 Agency: Department of Health and Human Services, Centers for Disease Control - NCCDPHP Category: Health Funding Amount: $500,000 |
| Summer Institute for Research Education in Biostatistics (R25 - Clinical Trials Not Allowed) Apply for RFA HL 19 019 Funding Number: RFA HL 19 019 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $240,000 |
| Family-to-Family Health Information Centers – Delaware, Hawaii, Maine, Montana, Nevada Apply for HRSA 18 113 Funding Number: HRSA 18 113 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Office of Tribal Self-Governance Negotiation Cooperative Agreement Apply for HHS 2018 IHS TSGN 0001 Funding Number: HHS 2018 IHS TSGN 0001 Agency: Department of Health and Human Services, Indian Health Service Category: Health Funding Amount: $48,000 |
| Office of Tribal Self-Governance Planning Cooperative Agreement Apply for HHS 2018 IHS TSGP 0001 Funding Number: HHS 2018 IHS TSGP 0001 Agency: Department of Health and Human Services, Indian Health Service Category: Health Funding Amount: $120,000 |
| PPHF2018-National Organization for Chronic Disease Prevention and Health Promotion-financed in part by 2018 Prevention and Public Health Funds Apply for CDC RFA DP18 1814 Funding Number: CDC RFA DP18 1814 Agency: Department of Health and Human Services, Centers for Disease Control - NCCDPHP Category: Health Funding Amount: $3,000,000 |
| Limited Competition: Interaction of HIV Infection and Alcohol Abuse on Central Nervous System Morbidity (U01 Clinical Trial Not Allowed) Apply for RFA AA 18 011 Funding Number: RFA AA 18 011 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $800,000 |
| FY18 Announcement of Availability of Funds for Phase I Replicating Programs (Tier 1) Effective in the Promotion of Healthy Adolescence and the Reduction of Teenage Pregnancy and Associated Risk Behaviors Apply for AH TP1 18 001 Funding Number: AH TP1 18 001 Agency: Department of Health and Human Services, Office of the Assistant Secretary for Health Category: Health Funding Amount: $500,000 |
| FY18 Announcement of the Availability of Funds for Phase I New and Innovative Strategies (Tier 2) to Prevent Teenage Pregnancy and Promote Healthy Adolescence Apply for AH TP2 18 001 Funding Number: AH TP2 18 001 Agency: Department of Health and Human Services, Office of the Assistant Secretary for Health Category: Health Funding Amount: $375,000 |
| NIH Director's Pioneer Award (DP1 - Clinical Trial Optional) Apply for RFA RM 18 007 Funding Number: RFA RM 18 007 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $700,000 |
| Tribal Behavioral Health Grant Program (Short Title: Native Connections) Apply for SM 18 017 Funding Number: SM 18 017 Agency: Department of Health and Human Services, Substance Abuse and Mental Health Services Adminis Category: Health Funding Amount: $250,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "SP 18 006", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.